1-(1,3-benzothiazol-2-yl)-3-(4-chlorophenyl)-1H-pyrazol-5-ol
- $160 - $700
- Product name: 1-(1,3-benzothiazol-2-yl)-3-(4-chlorophenyl)-1H-pyrazol-5-ol
- CAS: 378203-46-4
- MF: C16H10ClN3OS
- MW: 327.79
- EINECS:
- MDL Number:MFCD02375702
- Synonyms:1-(1,3-benzothiazol-2-yl)-3-(4-chlorophenyl)-1H-pyrazol-5-ol;1H-Pyrazol-5-ol, 1-(2-benzothiazolyl)-3-(4-chlorophenyl)-;1-(Benzo[d]thiazol-2-yl)-3-(4-chlorophenyl)-1H-pyrazol-5-ol
4 prices
Selected condition:
Brand
- Crysdot
- Matrix Scientific
Package
- 0.500g
- 1g
- 5g
- ManufacturerCrysdot
- Product numberCD11132914
- Product description1-(Benzo[d]thiazol-2-yl)-3-(4-chlorophenyl)-1H-pyrazol-5-ol 97%
- Packaging5g
- Price$527
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number158289
- Product description1-(1,3-Benzothiazol-2-yl)-3-(4-chlorophenyl)-1H-pyrazol-5-ol
- Packaging0.500g
- Price$160
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number158289
- Product description1-(1,3-Benzothiazol-2-yl)-3-(4-chlorophenyl)-1H-pyrazol-5-ol
- Packaging1g
- Price$200
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number158289
- Product description1-(1,3-Benzothiazol-2-yl)-3-(4-chlorophenyl)-1H-pyrazol-5-ol
- Packaging5g
- Price$700
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11132914 | 1-(Benzo[d]thiazol-2-yl)-3-(4-chlorophenyl)-1H-pyrazol-5-ol 97% | 5g | $527 | 2021-12-16 | Buy |
Matrix Scientific | 158289 | 1-(1,3-Benzothiazol-2-yl)-3-(4-chlorophenyl)-1H-pyrazol-5-ol | 0.500g | $160 | 2021-12-16 | Buy |
Matrix Scientific | 158289 | 1-(1,3-Benzothiazol-2-yl)-3-(4-chlorophenyl)-1H-pyrazol-5-ol | 1g | $200 | 2021-12-16 | Buy |
Matrix Scientific | 158289 | 1-(1,3-Benzothiazol-2-yl)-3-(4-chlorophenyl)-1H-pyrazol-5-ol | 5g | $700 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|